S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
Log in
NASDAQ:FRSX

FORESIGHT AUTON/S Stock Forecast, Price & News

$0.86
-0.05 (-5.49 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.85
Now: $0.86
$0.92
50-Day Range
$0.86
MA: $0.95
$1.14
52-Week Range
$0.46
Now: $0.86
$1.95
Volume596,627 shs
Average Volume2.24 million shs
Market Capitalization$44.53 million
P/E RatioN/A
Dividend YieldN/A
Beta2.21
Foresight Autonomous Holdings Ltd., a technology company, designs, develops, and commercializes stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry in Israel. It develops advanced driver assistance systems for accident prevention, which are designed to provide real-time information about a vehicle's surroundings while in motion. The company was formerly known as Asia Development (A.D.B.M.) Ltd. and changed its name to Foresight Autonomous Holdings Ltd. in 2016. Foresight Autonomous Holdings Ltd. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
Current SymbolNASDAQ:FRSX
CUSIPN/A
Phone972-77-970-9030
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.62 per share

Profitability

Net Income$-15,440,000.00

Miscellaneous

Market Cap$44.53 million
Next Earnings Date11/16/2020 (Estimated)
OptionableNot Optionable
$0.86
-0.05 (-5.49 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FRSX News and Ratings via Email

Sign-up to receive the latest news and ratings for FRSX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











FORESIGHT AUTON/S (NASDAQ:FRSX) Frequently Asked Questions

How has FORESIGHT AUTON/S's stock price been impacted by Coronavirus?

FORESIGHT AUTON/S's stock was trading at $0.6501 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FRSX shares have increased by 32.3% and is now trading at $0.86.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of FORESIGHT AUTON/S?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FORESIGHT AUTON/S in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for FORESIGHT AUTON/S
.

When is FORESIGHT AUTON/S's next earnings date?

FORESIGHT AUTON/S is scheduled to release its next quarterly earnings announcement on Monday, November 16th 2020.
View our earnings forecast for FORESIGHT AUTON/S
.

How were FORESIGHT AUTON/S's earnings last quarter?

FORESIGHT AUTON/S (NASDAQ:FRSX) announced its earnings results on Thursday, August, 20th. The company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.11) by $0.01.
View FORESIGHT AUTON/S's earnings history
.

Are investors shorting FORESIGHT AUTON/S?

FORESIGHT AUTON/S saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 124,400 shares, an increase of 24.8% from the September 15th total of 99,700 shares. Based on an average daily trading volume, of 2,090,000 shares, the days-to-cover ratio is presently 0.1 days.
View FORESIGHT AUTON/S's Short Interest
.

Who are some of FORESIGHT AUTON/S's key competitors?

What other stocks do shareholders of FORESIGHT AUTON/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FORESIGHT AUTON/S investors own include Sorrento Therapeutics (SRNE), Biocept (BIOC), CHF Solutions (CHFS), Check-Cap (CHEK), NIO (NIO), Electrameccanica Vehicles (SOLO), Blink Charging (BLNK), BioNano Genomics (BNGO), Jaguar Health (JAGX) and KITOV PHARMA LT/S (KTOV).

Who are FORESIGHT AUTON/S's key executives?

FORESIGHT AUTON/S's management team includes the following people:
  • Mr. Haim Siboni, CEO & Director (Age 60)
  • Mr. Eli Yoresh, Chief Financial Officer (Age 49)
  • Mr. Ariel Dor, VP of Mergers & Acquisitions (Age 37)
  • Mr. Doron Cohadier, VP of Bus. Devel. (Age 44)
  • Mr. Dror Elbaz, COO & Deputy CEO of Eye-Net Mobile Ltd (Age 40)

What is FORESIGHT AUTON/S's stock symbol?

FORESIGHT AUTON/S trades on the NASDAQ under the ticker symbol "FRSX."

Who are FORESIGHT AUTON/S's major shareholders?

FORESIGHT AUTON/S's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Psagot Investment House Ltd. (0.63%) and Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD (0.23%).

Which institutional investors are selling FORESIGHT AUTON/S stock?

FRSX stock was sold by a variety of institutional investors in the last quarter, including Psagot Investment House Ltd..

Which institutional investors are buying FORESIGHT AUTON/S stock?

FRSX stock was bought by a variety of institutional investors in the last quarter, including Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD.

How do I buy shares of FORESIGHT AUTON/S?

Shares of FRSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is FORESIGHT AUTON/S's stock price today?

One share of FRSX stock can currently be purchased for approximately $0.86.

How big of a company is FORESIGHT AUTON/S?

FORESIGHT AUTON/S has a market capitalization of $44.53 million.

What is FORESIGHT AUTON/S's official website?

The official website for FORESIGHT AUTON/S is www.foresightauto.com.

How can I contact FORESIGHT AUTON/S?

FORESIGHT AUTON/S's mailing address is 7 GOLDA MEIR STREET, NESS ZIONA L3, 7403650. The company can be reached via phone at 972-77-970-9030 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.